NeuroPace posts Q2 revenue $23.5M (+22% YoY); raises FY2025 revenue and margin guidance

NeuroPace Inc

2025-Q2 EPS reported -$0.47 vs consensus -$0.23 ▼ miss (-107.0%)

Revenue grew 22% YoY to $23.5M; RNS System revenue up 16% in Q2.
Full-year 2025 revenue guidance raised to $94-98M (previous $93-97M).
Gross margin 77.1% in Q2; FY margin guidance increased to 75-76%.
Net loss $8.7M vs $7.5M; free cash flow improved to ($2.3M).
NAUTILUS IGE study missed primary endpoint but showed 79% GTC seizure reduction at 12 months.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.